HighCape Capital Acquisition in an 8-K filing said its shareholders voted to approve the proposed merger with protein sequencing company Quantum-Si.
Nearly 39 percent of eligible shares voted in the transaction. The SPAC did not disclose redemptions, if any.
The combined company is expected to trade on the Nasdaq under QSI.
The transaction will deliver up to $540 million of gross proceeds, including up to $115 million of cash held in HighCape’s trust account (assuming no redemptions). The transaction is supported by a $425 million PIPE at $10 per share.
Quantum-Si has created a protein sequencing platform with the goal of revolutionizing the growing field of proteomics. Their semiconductor chip has the power to decode the molecules of life, starting with proteins, and holds the potential to expand the scale of the genomics and proteomics market beyond that of next-generation DNA sequencing, the company said in a statement. Read more.
